Assignee
STICHTING KATHOLIEKE UNIV
NL·38 granted patents·22 pending applications·247 citations·filing 1983–2021
Top patents by PatentIndex Score
60 records- 0195US7138235B2Nucleic acid molecules comprising the promoter for PCA3, and uses thereofSTICHTING KATHOLIEKE UNIV·Filed 2005·Granted Nov 21, 2006·43 cites·16 claims
- 0292US7960109B2mRNA ratios in urinary sediments and/or urine as a prognostic and/or theranostic marker for prostate cancerSTICHTING KATHOLIEKE UNIV·Filed 2005·Granted Jun 14, 2011·20 cites·22 claims
- 0391US7632643B2PCA3, PCA3 genes, and methods of useSTICHTING KATHOLIEKE UNIV·Filed 2005·Granted Dec 15, 2009·20 cites·29 claims
- 0487US6897024B2Nucleic acid molecules comprising the promoter for PCA3, and uses thereofSTICHTING KATHOLIEKE UNIV·Filed 2001·Granted May 24, 2005·32 cites·15 claims
- 0586US10647985B2Antisense oligonucleotides for the treatment of Leber congenital amaurosisSTICHTING KATHOLIEKE UNIV·Filed 2018·Granted May 12, 2020·2 cites·14 claims
- 0685US10314508B2Brain computer interface using broadband evoked potentialsSTICHTING KATHOLIEKE UNIV·Filed 2015·Granted Jun 11, 2019·29 cites·13 claims
- 0784US10131910B2Antisense oligonucleotides for the treatment of Usher syndrome type 2STICHTING KATHOLIEKE UNIV·Filed 2015·Granted Nov 20, 2018·6 cites·7 claims
- 0883US10167470B2Antisense oligonucleotides for the treatment of leber congenital amaurosisSTICHTING KATHOLIEKE UNIV·Filed 2018·Granted Jan 1, 2019·3 cites·11 claims
- 0983US9096907B2Prostate cancer prognostic compositions and kitsSTICHTING KATHOLIEKE UNIV·Filed 2013·Granted Aug 4, 2015·3 cites·21 claims
- 1080US8054713B2Magneto-optical switching device and method for switching a magnetizable mediumSTICHTING KATHOLIEKE UNIV·Filed 2006·Granted Nov 8, 2011·6 cites·22 claims
- 1177US11400274B2Heart support device with directional flow assistSTICHTING KATHOLIEKE UNIV·Filed 2019·Granted Aug 2, 2022·3 cites·18 claims
- 1277US10098992B2Heart support deviceSTICHTING KATHOLIEKE UNIV·Filed 2015·Granted Oct 16, 2018·7 cites·18 claims
- 1376US8345516B2Magneto-optical switching device and method for switching a magnetizable mediumSTICHTING KATHOLIEKE UNIV·Filed 2011·Granted Jan 1, 2013·6 cites·18 claims
- 1474US10745699B2Antisense oligonucleotides for the treatment of Usher syndrome type 2STICHTING KATHOLIEKE UNIV·Filed 2018·Granted Aug 18, 2020·3 cites·24 claims
- 1572US10465230B2Chemiluminescence-based haemostasis assaySTICHTING KATHOLIEKE UNIV·Filed 2017·Granted Nov 5, 2019·1 cites·15 claims
- 1667US12054716B2Antisense oligonucleotides for the treatment of Stargardt diseaseSTICHTING KATHOLIEKE UNIV·Filed 2021·Granted Aug 6, 2024·0 cites·11 claims
- 1767US10266809B2Polymer suitable for use in cell cultureSTICHTING KATHOLIEKE UNIV·Filed 2014·Granted Apr 23, 2019·2 cites·12 claims
- 1866US12179603B2National individual floating transport infrastructureSTICHTING KATHOLIEKE UNIV·Filed 2019·Granted Dec 31, 2024·2 cites·16 claims
- 1966US9763748B2Anatomical image projection systemSTICHTING KATHOLIEKE UNIV·Filed 2015·Granted Sep 19, 2017·5 cites·21 claims
- 2065US7691591B2Methods of identifying and isolating cells expressing DC-signSTICHTING KATHOLIEKE UNIV·Filed 2003·Granted Apr 6, 2010·1 cites·7 claims
- 2165US4916089AProcess for the epitaxial production of semiconductor stock materialSTICHTING KATHOLIEKE UNIV·Filed 1988·Granted Apr 10, 1990·32 cites·4 claims
- 2265US2009233285A1Specific method of prostate cancer detection based on pca3 gene, and kits thereforSTICHTING KATHOLIEKE UNIV·Filed 2008·Application pending·0 cites
- 2364US8920802B2Methods for the treatment or prevention of systemic sclerosisSTICHTING KATHOLIEKE UNIV·Filed 2013·Granted Dec 30, 2014·1 cites·6 claims
- 2461US7541032B2Antigen uptake receptor for Candida albicans on dendritic cellsSTICHTING KATHOLIEKE UNIV·Filed 2003·Granted Jun 2, 2009·0 cites·16 claims
- 2560US2009285839A1Antigen uptake receptor for candida albicans on dendritic cellsSTICHTING KATHOLIEKE UNIV·Filed 2009·Application pending·0 cites
- 2660US2015307948A1Prostate cancer prognostic compositions and kitsSTICHTING KATHOLIEKE UNIV·Filed 2015·Application pending·0 cites
- 2760US2015105516A1Method for the preparation of high molecular weight oligo(alkylene glycol) functionalized polyisocyanopeptidesSTICHTING KATHOLIEKE UNIV·Filed 2014·Application pending·0 cites
- 2859US2017342414A1Antisense oligonucleotides for the treatment of leber congenital amaurosisSTICHTING KATHOLIEKE UNIV·Filed 2017·Application pending·0 cites
- 2959US2020352977A1Antisense oligonucleotides for the treatment of leber congenital amaurosisSTICHTING KATHOLIEKE UNIV·Filed 2020·Application pending·0 cites
- 3058US4692542APhosphorylating agentSTICHTING KATHOLIEKE UNIV·Filed 1984·Granted Sep 8, 1987·5 cites·4 claims
- 3157US11739324B2Antisense oligonucleotides rescue aberrant splicing of ABCA4STICHTING KATHOLIEKE UNIV·Filed 2019·Granted Aug 29, 2023·0 cites·19 claims
- 3256US9259466B2Methods for the treatment or prevention of systemic sclerosisSTICHTING KATHOLIEKE UNIV·Filed 2014·Granted Feb 16, 2016·0 cites·5 claims
- 3356US2022127674A1Methods for detecting circulating stromal cellsSTICHTING KATHOLIEKE UNIV·Filed 2020·Application pending·0 cites
- 3456US2021169838A1Novel class of compounds for the treatment of cardiovascular disease.STICHTING KATHOLIEKE UNIV·Filed 2020·Application pending·0 cites
- 3555US11236333B2Antisense oligonucleotides for the treatment of Stargardt diseaseSTICHTING KATHOLIEKE UNIV·Filed 2017·Granted Feb 1, 2022·0 cites·12 claims
- 3648US10085779B2Intramedullary device for mid-shaft clavicle fracturesSTICHTING KATHOLIEKE UNIV·Filed 2014·Granted Oct 2, 2018·2 cites·23 claims
- 3748US2018228829A1Antisense oligonucleotides for the treatment of leber congenital amaurosisSTICHTING KATHOLIEKE UNIV·Filed 2015·Application pending·0 cites
- 3847US2022049250A1Antisense Oligonucleotides Rescue Aberrant Splicing of ABCA4STICHTING KATHOLIEKE UNIV·Filed 2019·Application pending·0 cites
- 3945US2016121039A1Methods for the treatment or prevention of systemic sclerosisSTICHTING KATHOLIEKE UNIV·Filed 2016·Application pending·0 cites
- 4045US2009312741A1Bioresorbable composition and a medical device comprising said compositionSTICHTING KATHOLIEKE UNIV·Filed 2007·Application pending·0 cites
- 4143US4820712ASparsomycin (SC-RS) compounds having antitumor activity, a process for their preparation and pharmaceutical compositions containing sparsomycin (SC-RS) compoundsSTICHTING KATHOLIEKE UNIV·Filed 1986·Granted Apr 11, 1989·3 cites·10 claims
- 4242US2018362935A1A renal cell line with stable transporter expressionSTICHTING KATHOLIEKE UNIV·Filed 2016·Application pending·0 cites
- 4341US2019038588A1Novel class of compounds for the treatment of cardiovascular diseaseSTICHTING KATHOLIEKE UNIV·Filed 2017·Application pending·0 cites
- 4441US2021087583A1Minigene for the treatment of Usher syndrome type 2a and USH2A-associated retinitis pigmentosa.STICHTING KATHOLIEKE UNIV·Filed 2019·Application pending·0 cites
- 4540US4581360ASparsomycin (Sc -Rs) derivative; pharmaceutical composition having anti-tumor activitySTICHTING KATHOLIEKE UNIV·Filed 1983·Granted Apr 8, 1986·3 cites·3 claims
- 4639US2020032347A1RNA profiling for individualized diet and treatment advice.STICHTING KATHOLIEKE UNIV·Filed 2018·Application pending·0 cites
- 4738US2018237749A1Improved method for ex vivo expansion CD34+HSPCs into NK cells using an aryl hydrocarbon receptor antagonistSTICHTING KATHOLIEKE UNIV·Filed 2016·Application pending·0 cites
- 4837US11035860B2Auto-active and intracellular mutant of METSTICHTING KATHOLIEKE UNIV·Filed 2015·Granted Jun 15, 2021·0 cites·4 claims
- 4936US11053349B2Biomimetic networks comprising polyisocyanopeptide hydrogelsSTICHTING KATHOLIEKE UNIV·Filed 2017·Granted Jul 6, 2021·0 cites·19 claims
- 5035US11840705B2Biomimetic double network hydrogelsSTICHTING KATHOLIEKE UNIV·Filed 2018·Granted Dec 12, 2023·0 cites·18 claims
Showing the top 50 of 60 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when STICHTING KATHOLIEKE UNIV files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →